Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007205845> ?p ?o ?g. }
- W2007205845 endingPage "205" @default.
- W2007205845 startingPage "191" @default.
- W2007205845 abstract "Experience suggests that African Americans may express autoimmune disease differently than other racial groups. In the context of systemic sclerosis (scleroderma), we sought to determine whether race was related to a more adverse expression of disease. Between January 1, 1990, and December 31, 2009, a total of 409 African American and 1808 white patients with scleroderma were evaluated at a single university medical center. While the distribution by sex was virtually identical in both groups, at 82% female, African American patients presented to the center at a younger mean age than white patients (47 vs. 53 yr; p < 0.001). Two-thirds of white patients manifested the limited cutaneous subset of disease, whereas the majority of African American patients manifested the diffuse cutaneous subset (p < 0.001). The proportion seropositive for anticentromere antibody was nearly 3-fold greater among white patients, at 34%, compared to African American patients (12%; p < 0.001). Nearly a third of African American (31%) patients had autoantibodies to topoisomerase, compared to 19% of white patients (p = 0.001). Notably, African American patients experienced an increase in prevalence of cardiac (adjusted odds ratio [OR], 1.6; 95% confidence interval [CI], 1.3–2.2), renal (OR, 1.6; 95% CI, 1.2–2.1), digital ischemia (OR, 1.5; 95% CI, 1.4–2.2), muscle (OR, 1.7; 95% CI, 1.3–2.3), and restrictive lung (OR, 6.9; 95% CI, 5.1–9.4) disease. Overall, 700 (32%) patients died (159 African American; 541 white). The cumulative incidence of mortality at 10 years was 43% among African American patients compared to 35% among white patients (log-rank p = 0.0011). Compared to white patients, African American patients experienced an 80% increase in risk of mortality (relative risk [RR], 1.8; 95% CI, 1.4–2.2), after adjustment for age at disease onset and disease duration. Further adjustment by sex, disease subtype, and scleroderma-specific autoantibody status, and for the socioeconomic measures of educational attainment and health insurance status, diminished these risk estimates (RR, 1.3; 95% CI, 1.0–1.6). The heightened risk of mortality persisted in strata defined by age at disease onset, diffuse cutaneous disease, anticentromere seropositivity, decade of care at the center, and among women. These findings support the notion that race is related to a distinct phenotypic profile in scleroderma, and a more unfavorable prognosis among African Americans, warranting heightened diagnostic evaluation and vigilant care of these patients. Further, we provide a chronologic review of the literature regarding race, organ system involvement, and mortality in scleroderma; we furnish synopses of relevant reports, and summarize findings." @default.
- W2007205845 created "2016-06-24" @default.
- W2007205845 creator A5000610272 @default.
- W2007205845 creator A5004382663 @default.
- W2007205845 creator A5004999384 @default.
- W2007205845 creator A5008093033 @default.
- W2007205845 creator A5009211703 @default.
- W2007205845 creator A5042321849 @default.
- W2007205845 creator A5068528030 @default.
- W2007205845 creator A5072246307 @default.
- W2007205845 date "2013-07-01" @default.
- W2007205845 modified "2023-10-13" @default.
- W2007205845 title "Race and Association With Disease Manifestations and Mortality in Scleroderma" @default.
- W2007205845 cites W1588398650 @default.
- W2007205845 cites W1736835472 @default.
- W2007205845 cites W1915469550 @default.
- W2007205845 cites W1933923825 @default.
- W2007205845 cites W1969225583 @default.
- W2007205845 cites W1973831908 @default.
- W2007205845 cites W1998291301 @default.
- W2007205845 cites W2006454795 @default.
- W2007205845 cites W2012071958 @default.
- W2007205845 cites W2035608725 @default.
- W2007205845 cites W2040990606 @default.
- W2007205845 cites W2048350130 @default.
- W2007205845 cites W2049770223 @default.
- W2007205845 cites W2057086409 @default.
- W2007205845 cites W2064182881 @default.
- W2007205845 cites W2065830768 @default.
- W2007205845 cites W2066293475 @default.
- W2007205845 cites W2068952292 @default.
- W2007205845 cites W2069650976 @default.
- W2007205845 cites W2076436640 @default.
- W2007205845 cites W2101402364 @default.
- W2007205845 cites W2107431307 @default.
- W2007205845 cites W2108678383 @default.
- W2007205845 cites W2114012471 @default.
- W2007205845 cites W2120317399 @default.
- W2007205845 cites W2126273105 @default.
- W2007205845 cites W2134785685 @default.
- W2007205845 cites W2154622998 @default.
- W2007205845 cites W2168198817 @default.
- W2007205845 cites W2187668060 @default.
- W2007205845 cites W2318619461 @default.
- W2007205845 cites W4233274466 @default.
- W2007205845 cites W4293241248 @default.
- W2007205845 doi "https://doi.org/10.1097/md.0b013e31829be125" @default.
- W2007205845 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4553970" @default.
- W2007205845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23793108" @default.
- W2007205845 hasPublicationYear "2013" @default.
- W2007205845 type Work @default.
- W2007205845 sameAs 2007205845 @default.
- W2007205845 citedByCount "100" @default.
- W2007205845 countsByYear W20072058452013 @default.
- W2007205845 countsByYear W20072058452014 @default.
- W2007205845 countsByYear W20072058452015 @default.
- W2007205845 countsByYear W20072058452016 @default.
- W2007205845 countsByYear W20072058452017 @default.
- W2007205845 countsByYear W20072058452018 @default.
- W2007205845 countsByYear W20072058452019 @default.
- W2007205845 countsByYear W20072058452020 @default.
- W2007205845 countsByYear W20072058452021 @default.
- W2007205845 countsByYear W20072058452022 @default.
- W2007205845 countsByYear W20072058452023 @default.
- W2007205845 crossrefType "journal-article" @default.
- W2007205845 hasAuthorship W2007205845A5000610272 @default.
- W2007205845 hasAuthorship W2007205845A5004382663 @default.
- W2007205845 hasAuthorship W2007205845A5004999384 @default.
- W2007205845 hasAuthorship W2007205845A5008093033 @default.
- W2007205845 hasAuthorship W2007205845A5009211703 @default.
- W2007205845 hasAuthorship W2007205845A5042321849 @default.
- W2007205845 hasAuthorship W2007205845A5068528030 @default.
- W2007205845 hasAuthorship W2007205845A5072246307 @default.
- W2007205845 hasBestOaLocation W20072058451 @default.
- W2007205845 hasConcept C107130276 @default.
- W2007205845 hasConcept C120665830 @default.
- W2007205845 hasConcept C121332964 @default.
- W2007205845 hasConcept C126322002 @default.
- W2007205845 hasConcept C151730666 @default.
- W2007205845 hasConcept C156957248 @default.
- W2007205845 hasConcept C180032290 @default.
- W2007205845 hasConcept C203014093 @default.
- W2007205845 hasConcept C2779134260 @default.
- W2007205845 hasConcept C2779343474 @default.
- W2007205845 hasConcept C2779625490 @default.
- W2007205845 hasConcept C2779967694 @default.
- W2007205845 hasConcept C2781222467 @default.
- W2007205845 hasConcept C44249647 @default.
- W2007205845 hasConcept C61511704 @default.
- W2007205845 hasConcept C71924100 @default.
- W2007205845 hasConcept C86803240 @default.
- W2007205845 hasConcept C90924648 @default.
- W2007205845 hasConceptScore W2007205845C107130276 @default.
- W2007205845 hasConceptScore W2007205845C120665830 @default.
- W2007205845 hasConceptScore W2007205845C121332964 @default.
- W2007205845 hasConceptScore W2007205845C126322002 @default.
- W2007205845 hasConceptScore W2007205845C151730666 @default.
- W2007205845 hasConceptScore W2007205845C156957248 @default.